
PERSERIS® is indicated for the
treatment of schizophrenia in adults.
Needle sizes of select LAIs for schizophrenia
LAI=long-acting injectable.
Images are to scale but not actual size. Needle sizes are representations of the gauges and lengths outlined in the Prescribing Information of each product as of November 2023. Display not meant to draw comparisons of safety or efficacy.
PERSERIS
(risperidone)1
Subcutaneous
Gauge: 18
Length: 5/8"
INVEGA SUSTENNA®
(paliperidone palmitate)2
Intramuscular
Gauge: 23
Length: 1"

Gauge: 22
Length: 1.5"

RISPERDAL CONSTA®
(risperidone)3
Intramuscular
Gauge: 21
Length: 1"

Gauge: 20
Length: 2"

ARISTADA®
(aripiparazole lauroxil)4
Intramuscular
Gauge: 21
Length: 1"

Gauge: 20
Length: 1.5"

Gauge: 20
Length: 2"

ARISTADA INITO®
(aripiparazole lauroxil)5
Intramuscular
Gauge: 21
Length: 1"

Gauge: 20
Length: 1.5"

Gauge: 20
Length: 2"

ABILIFY MAINTENA®
(aripiparazole)6
Intramuscular
Gauge: 23
Length: 1"

Gauge: 22
Length: 1.5"

Gauge: 21
Length: 2"

INVEGA SUSTENNA® and RISPERDAL CONSTA® are registered trademarks of Janssen Pharmaceuticals, Inc. ARISTADA® is a registered trademark of Alkermes Pharma Ireland Limited. ARISTADA INITIO® is a registered trademark of Alkermes Pharma Ireland Limited. ABILIFY MAINTENA® is a registered trademark of Otsuka Pharmaceuticals, Inc.
Once-Monthly Dosing